[go: up one dir, main page]

WO2008045009A3 - Forme posologique pharmaceutique - Google Patents

Forme posologique pharmaceutique Download PDF

Info

Publication number
WO2008045009A3
WO2008045009A3 PCT/TR2007/000121 TR2007000121W WO2008045009A3 WO 2008045009 A3 WO2008045009 A3 WO 2008045009A3 TR 2007000121 W TR2007000121 W TR 2007000121W WO 2008045009 A3 WO2008045009 A3 WO 2008045009A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage form
coating
pharmaceutical dosage
core tablet
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2007/000121
Other languages
English (en)
Other versions
WO2008045009A2 (fr
Inventor
Abdullah Uslu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOBEL ILAC SAN VE TIC AS
Nobel Ilac San Ve Tic A S
Original Assignee
NOBEL ILAC SAN VE TIC AS
Nobel Ilac San Ve Tic A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOBEL ILAC SAN VE TIC AS, Nobel Ilac San Ve Tic A S filed Critical NOBEL ILAC SAN VE TIC AS
Priority to EP07852324A priority Critical patent/EP2086517A2/fr
Publication of WO2008045009A2 publication Critical patent/WO2008045009A2/fr
Publication of WO2008045009A3 publication Critical patent/WO2008045009A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention comprenant un ingrédient actif pantoprazole consiste en un comprimé de cœur de forme posologique solide pharmaceutique, un enrobage entérique et un pré-enrobage entre le comprimé de cœur et l'enrobage entérique. Le comprimé de cœur contient l'ingrédient actif pantoprazole conjointement avec de la carboxyméthylcellulose sodique en tant que liant et de l'isomalt en tant que charge.
PCT/TR2007/000121 2006-10-10 2007-10-10 Forme posologique pharmaceutique Ceased WO2008045009A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07852324A EP2086517A2 (fr) 2006-10-10 2007-10-10 Forme posologique pharmaceutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2006/05624A TR200605624A2 (tr) 2006-10-10 2006-10-10 Farmasötik dozaj şekli
TR2006/05624 2006-10-10

Publications (2)

Publication Number Publication Date
WO2008045009A2 WO2008045009A2 (fr) 2008-04-17
WO2008045009A3 true WO2008045009A3 (fr) 2008-12-31

Family

ID=39283297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2007/000121 Ceased WO2008045009A2 (fr) 2006-10-10 2007-10-10 Forme posologique pharmaceutique

Country Status (3)

Country Link
EP (1) EP2086517A2 (fr)
TR (1) TR200605624A2 (fr)
WO (1) WO2008045009A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105380919A (zh) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 一种泮托拉唑钠肠溶片及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001624A1 (fr) * 1994-07-08 1996-01-25 Astra Aktiebolag Preparation pharmaceutique composite renfermant un inhibiteur de pompe a protons
DE19752843A1 (de) * 1997-11-28 1999-07-01 Byk Gulden Lomberg Chem Fab Arzneimittelzubereitung in Tabletten- oder Pelletform für Pantoprazol und Omeprazol
EP1257256A1 (fr) * 2000-02-17 2002-11-20 Alpharma APS Procede de production de pellets vecteurs de medicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001624A1 (fr) * 1994-07-08 1996-01-25 Astra Aktiebolag Preparation pharmaceutique composite renfermant un inhibiteur de pompe a protons
DE19752843A1 (de) * 1997-11-28 1999-07-01 Byk Gulden Lomberg Chem Fab Arzneimittelzubereitung in Tabletten- oder Pelletform für Pantoprazol und Omeprazol
EP1257256A1 (fr) * 2000-02-17 2002-11-20 Alpharma APS Procede de production de pellets vecteurs de medicaments

Also Published As

Publication number Publication date
WO2008045009A2 (fr) 2008-04-17
EP2086517A2 (fr) 2009-08-12
TR200605624A2 (tr) 2008-05-21

Similar Documents

Publication Publication Date Title
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
IL194290A (en) A complicated rna unit containing a two-strand region, a medicinal product containing it, a method of preparation and use thereof
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
PT2040755E (pt) Combinação de um inibidor de colinesterase e um composto com afinidade para o receptor 5-ht6
WO2006011159A3 (fr) Composition pharmaceutique stabilisee contenant du sodium de rabeprazole presentant une biodisponibilite amelioree
WO2008129517A3 (fr) Composition pharmaceutique à libération prolongée stabilisée de rabéprazole
WO2010017821A8 (fr) Comprimés enrobés avec une surface de dégradation résiduelle dans le temps
WO2009059701A3 (fr) Comprimés à libération prolongée contenant de l'hydromorphone
WO2012022919A3 (fr) Formulations à base de nalbuphine et leurs utilisations
IL196697A (en) Use of 4 Hydroxy-Alpha-Phenyl Butyl Nitron or its Derivatives to Prepare a Cure for Sensory-Neural Hearing Loss
WO2011140446A3 (fr) Formulations pharmaceutiques
WO2009019477A3 (fr) Revêtement
WO2011005052A3 (fr) Nouveaux dérivés imidazole-4-carboxamide contenant de l'arylpipérazine et composition pharmaceutique contenant ces dérivés
BRPI0720314A2 (pt) Composição, e, usos de uma composição e de um composto de triazol.
WO2011107944A3 (fr) Forme pharmaceutique à libération modifiée
WO2009135951A3 (fr) Procédé pour préparer un comprimé contenant de la metformine
WO2010018175A3 (fr) Formulation pharmaceutique orale pour l’oméprazole comprenant une couche de séparation spécifique
WO2009133455A3 (fr) Composition pharmaceutique de clopidogrel
WO2007141743A3 (fr) Forme pharmaceutique de comprimé comprenant de la cétirizine et de la pseudoéphédrine
WO2008045009A3 (fr) Forme posologique pharmaceutique
WO2009150238A3 (fr) Compositions pharmaceutiques orales résistantes au suc gastrique comprenant de la duloxétine ou ses dérivés pharmaceutiquement acceptables
WO2009110010A3 (fr) Forme posologique orale stable
WO2009087657A3 (fr) Composition pharmaceutique stable de duloxétine et son procédé de préparation
WO2009087675A3 (fr) Nouvelles compositions pharmaceutiques enrobées de lévétiracétam, à libération prolongée
WO2009006299A3 (fr) Systèmes à multiples particules

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007852324

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07852324

Country of ref document: EP

Kind code of ref document: A2